Approval · Notice of Compliance 1069 · 2000
ALLERGY RELIEF: Notice of Compliance 1069
Issued March 15, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1069
- Date
- March 15, 2000
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Therapeutic class
- Histamine h1 receptor antagonist
- Canadian reference product
- REACTINE (Pfizer Canada Ulc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ALLERGY RELIEF | 02241912 | — |
Medicinal ingredients
- CETIRIZINE HYDROCHLORIDE 5 MG per TAB